Automated Bio-Banking Market Trends, Share & Demand by 2034

Coverage: Automated Bio-Banking Market covers analysis By Sample Type (Blood Products (plasma, serum, whole blood), Human Tissues, DNA/RNA Samples, Cell Lines, Other Bio-specimens), Application (Clinical Diagnostics, Drug Discovery & Development, Genomics & Proteomics Research, Regenerative Medicine & Cell Therapy, and Population-based Biobanking / Epidemiology Studies), Automation Level (Fully Automated Bio-banking Systems and Semi-automated Bio-banking Systems), End-Use Industry (Biopharmaceutical & Pharmaceutical Companies, Academic & Research Institutes, Hospitals & Clinical Laboratories and Contract Research Organizations (CROs) / Public Biobanks), and Geography (North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America)

  • Status : Upcoming
  • Report Code : TIPRE00043067
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format

The Automated Bio-Banking Market is projected to reach approximately US$ 10.80 billion by 2034, from a base of US$ 4.31 billion in 2025. The market is anticipated to register a CAGR of 10.72% during 2026-2034.

Automated Bio-Banking Market Analysis

The automated bio-banking market forecast indicates significant growth, owing to the increasing demand for high-throughput storage, retrieval, and management of biological samples, the rising importance of precision medicine and multi-omics research, and the drive toward automation to reduce manual error and operational costs. Key enablers include robotics, advanced informatics, integration with laboratory and biobank management systems, and growing regulatory and quality-assurance demands.

Automated Bio-Banking Market Overview

Automated bio-banking refers to highly automated systems and platforms that manage the collection, storage, retrieval, tracking, and analysis of biological samples (blood, tissues, DNA/RNA, cell lines, and others) using robotics, informatics, cryogenic/controlled-temperature storage, and workflow automation. These systems support large-scale biorepositories in research institutes, pharmaceutical/biopharma companies, hospitals/clinical labs, and public biobanks. They enable improved sample traceability, faster access, enhanced throughput, better compliance, and reduced human error compared to manual or semi-automated setups.

Strategic InsightsAutomated Bio-Banking Market Drivers and Opportunities

Market Drivers:

  • Rising demand for operational efficiency and sample throughput in life sciences and biopharma R&D (e.g., genomics, proteomics, population-based studies).
  • Growing adoption of personalized medicine and large-scale cohort biobanking initiatives requires high-capacity, automated storage and retrieval systems.
  • Increasing emphasis on compliance, traceability, quality standards (e.g., ISO 20387 for biobanking), and the need to reduce human error and maintain specimen integrity over long durations.

Market Opportunities:

  • Expansion in emerging markets (Asia Pacific, Latin America, Middle East & Africa) where biobanking infrastructure is growing and automation offers scalable, cost-effective solutions.
  • Integration of automated bio-banking systems with AI/ML, advanced analytics, and informatics platforms to enable “smart biobanks” that link specimens with multi-omics data, clinical data, imaging, and metadata.
  • Growth of modular, scalable, cloud-connected, and interoperable biobanking solutions that can serve small-to-medium facilities as well as large national/regional biobanks.
Automated Bio-Banking Market Report Segmentation Analysis

The automated bio-banking market is analyzed across the following segments:

By Product:

  • Automated Sample Storage Systems
  • Automated Sample Processing Systems
  • Sample Retrieval & Tracking Systems
  • Software & Informatics Solutions

By Sample Type:

  • Blood Products (plasma, serum, whole blood)
  • Human Tissues
  • DNA/RNA Samples
  • Cell Lines
  • Other Bio-specimens

By Application:

  • Clinical Diagnostics
  • Drug Discovery & Development
  • Genomics & Proteomics Research
  • Regenerative Medicine & Cell Therapy
  • Population-based Biobanking / Epidemiology Studies

By Automation Level:

  • Fully Automated Bio-banking Systems
  • Semi-automated Bio-banking Systems

By End-Use Industry:

  • Biopharmaceutical & Pharmaceutical Companies
  • Academic & Research Institutes
  • Hospitals & Clinical Laboratories
  • Contract Research Organizations (CROs) / Public Biobanks

By Geography:

  • North America
  • Europe
  • Asia Pacific
  • South & Central America
  • Middle East & Africa
Market Report ScopeAutomated Bio-Banking Market Share Analysis by Geography

1. North America

  • Market Share: Holds the largest share currently, due to advanced healthcare & research infrastructure and high biopharma R&D activity.
  • Key Drivers: Strong adoption of large-scale biobanking initiatives, advanced automation infrastructure, regulatory compliance, and high investment in sample-centric research.
  • Trends: Shift toward cloud-connected biobank systems, robotic cryogenic storage, integration with informatics and data analytics platforms.

2. Europe

  • Market Share: Significant share, due to structured public-health initiatives, well-established research network, and biobank governance frameworks.
  • Key Drivers: Demand for GDPR- and ISO-compliant bio-banking platforms, public programs supporting biobanking infrastructure, research in genomics & precision medicine.
  • Trends: Cross-border data sharing frameworks, harmonized biobank standards, interoperable automated systems across national networks.

3. Asia Pacific

  • Market Share: Fastest-growing region, driven by expanding healthcare systems, rising medical research investment, and large population-based biobank initiatives.
  • Key Drivers: Government-led health IT and biobank programs, growing private healthcare/biopharma sectors, increasing sample volumes, and demand for automation.
  • Trends: Local manufacturing of automated systems, cost-sensitive modular solutions, language/localization features.

4. South & Central America

  • Market Share: Emerging market with strong growth potential as biobanking awareness and infrastructure rollout accelerate.
  • Key Drivers: Public-private partnerships in biobanking, increasing adoption of automation to improve limited resources, and expansion of specialist centers.
  • Trends: Cloud-based cost-effective solutions are gaining traction among small-to-medium biobanks, regional collaborations.

5. Middle East & Africa

  • Market Share: Developing market with considerable future potential, driven by national health infrastructure expansion and precision-medicine commitments.
  • Key Drivers: National e-health/biobank strategies, increasing investment in research infrastructure, and growing demand for medical-tourism-backed facilities.
  • Trends: Implementation of automated biobanking in integrated care/diagnostic networks, adoption of combined cryobank-informatics platforms.
Automated Bio-Banking Market Players Density: Understanding Its Impact on Business Dynamics

The automated bio-banking market features a high density of both global vendors and regional specialist providers. Competition is increasing, driven by vendors seeking differentiation via:

  • Seamless integration with laboratory information management systems (LIMS), electronic health records (EHRs), and research-informatics platforms
  • Scalable, cloud-connected, modular automated systems that serve both large national biobanks and smaller institutional facilities
  • AI/ML-enabled workflow optimization for retrieval, tracking, predictive maintenance, and analytics
  • Interoperability with third-party systems (labs, clinics, sample-sharing networks) and support for increasing sample volumes
Major Companies Operating in the Automated Bio-banking Market:
  1. Thermo Fisher Scientific Inc.
  2. Azenta Life Sciences
  3. Hamilton Company
  4. Tecan Group Ltd.
  5. Qiagen N.V.
  6. Greiner Bio‑One International GmbH
  7. LiCONiC AG
  8. ASKION GmbH
  9. PHC Holdings Corporation
  10. BioCision, LLC

Other companies analyzed during research:

  • Micronic Holding B.V.
  • Biobank AS
  • Ziath Ltd.
  • Promega Corporation.
  • Biomatrica, Inc.
  • Angelantoni Life Science Srl
  • Haier Biomedical
  • LabVantage Solutions, Inc
  • Sias AG
  • Biologix Group Limited
Automated Bio-Banking Market News and Recent Developments
  • For instance, several large biobank initiatives are investing in automation upgrades to support large cohort and multi-omics data research, reinforcing demand for automated bio-banking platforms.
  • Key vendors are increasingly launching AI-enabled retrieval and tracking modules for their automated storage systems, integrating robotics, informatics, and analytics to support next-generation biobanks.
Automated Bio-Banking Market Report Coverage and Deliverables

The “Automated Bio-banking Market Size and Forecast (2021–2034)” report offers:

  • Market size and forecast at global, regional, and country levels across all key segments (product, sample type, application, automation level, end-user).
  • Market trends, as well as market dynamics such as drivers, restraints, opportunities, and key challenges.
  • Detailed PEST and SWOT analyses.
  • Market analysis covering global and regional frameworks, major players, regulatory environment, and recent developments.
  • Industry landscape and competition analysis, including concentration, heat map analysis, prominent players, and recent strategic developments.
  • Detailed company profiles of leading players.
REGIONAL FRAMEWORK
World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are some of the major companies in the automated bio-banking market?

Major players include Thermo Fisher Scientific Inc., Azenta Life Sciences, Hamilton Company, Tecan Group Ltd., Qiagen N.V., Greiner Bio-One International GmbH, LiCONiC AG, ASKION GmbH, PHC Holdings Corporation, BioCision, LLC.

What are some of the key challenges hindering the automated bio-banking market growth?

Challenges include high upfront capital cost, complexity of integrating automated systems into existing infrastructures, data security and privacy concerns around biospecimen handling and tracking, and standardization gaps across biobank networks.

Which regions are leading in the adoption of automated bio-banking systems?

North America currently leads the market; Asia Pacific is the fastest-growing region thanks to expanding biomedical research infrastructure and government initiatives in countries such as China, India, and Japan.

Which component is gaining traction in the global automated bio-banking market?

While automated storage hardware remains critical, the software & informatics solutions segment is expected to grow fastest, driven by the need for sample tracking, data integration, and analytics.

What are the key drivers of the automated bio-banking market growth?

1. Rising demand for operational efficiency and high-throughput sample management.
2. Growing adoption of personalized medicine, genomics/proteomics research, and large-scale biobanks.
3. Increasing regulatory and quality-assurance requirements for biospecimen management and traceability.

Your Key Concerns Addressed - Question & Answer
Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.